Medics Autonomously Stopping Hemorrhage (MASH)

Location: Federal
Posted: Oct 8, 2025
Due: Nov 25, 2025
Agency: DEPT OF DEFENSE
Type of Government: Federal
Category:
  • A - Research and development
Solicitation No: DARPA-PS-25-34
Publication URL: To access bid details, please log in.
Follow
Medics Autonomously Stopping Hemorrhage (MASH)
Active
Contract Opportunity
Notice ID
DARPA-PS-25-34
Related Notice
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA)
Office
DEF ADVANCED RESEARCH PROJECTS AGCY
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information View Changes
  • Contract Opportunity Type: Solicitation (Updated)
  • Updated Published Date: Oct 08, 2025 11:57 am EDT
  • Original Published Date: Sep 16, 2025 04:47 pm EDT
  • Updated Date Offers Due: Nov 25, 2025 04:00 pm EST
  • Original Date Offers Due: Nov 25, 2025 04:00 pm EST
  • Inactive Policy: Manual
  • Updated Inactive Date: Dec 25, 2025
  • Original Inactive Date: Dec 25, 2025
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: AC12 - NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH
  • NAICS Code:
    • 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
  • Place of Performance:
Description View Changes
The purpose of Amendment 1 to DARPA-PS-25-34, the Medics Autonomously Stopping Hemorrhage (MASH) Program Solicitation (PS), is to clarify that proposal abstract submissions must include Attachments A-C. Details are provided in Attachment A, to mirror guidance provided in Section 4.1 of DARPA-PS-25-34.

The Defense Advanced Research Projects Agency (DARPA) is soliciting proposals to develop demonstrator autonomous systems to stabilize torso hemorrhage without need of a surgeon in forward medical sites, providing 48+ hours to reach definitive care. The Medics Autonomously Stopping Hemorrhage (MASH) program is seeking approaches that merge multi-modal automated bleed detection and localization with automated, minimally invasive robotic end effectors and sensors. MASH’s vision is to push the standard of pre-hospital hemorrhage control to 48 hours; stop lethal forms of torso hemorrhage without a surgeon; and provide minimally invasive surgery (MIS) a path to enter the trauma market and utilize full autonomy.
Attachments/Links
Contact Information View Changes
Contracting Office Address
  • 675 NORTH RANDOLPH STREET
  • ARLINGTON , VA 222032114
  • USA
Primary Point of Contact
Secondary Point of Contact


History

Related Document

Sep 16, 2025[Solicitation (Original)] Medics Autonomously Stopping Hemorrhage (MASH)
Daily notification on new contract opportunities

With GovernmentContracts, you can:

  • Find more opportunities and win more business
  • Receive daily alerts for all new bid opportunities
  • Get contract opportunities matched to your business
ONE WEEK FREE TRIAL

See also

...trauma care. RAPIID aims for this system to be fieldable, usable, and scalable, ...

DEPT OF DEFENSE

Bid Due: 6/24/2026

...a transformative, end-to-end resuscitation system that redefines far-forward trauma care. RAPIID aims...

DEPT OF DEFENSE

Bid Due: 6/24/2026

* Disclaimer: Information regarding bids, requests for proposals (RFPs), or requests for qualifications (RFQs) is provided on this website only for convenience and does not constitute official public notice. Persons wishing to respond to or inquire about bids, RFPs, or RFQs should contact the appropriate government department.